MEDTECH ACQUISITION CORP - *W EXP 12/22/202 (MTACW)

CUSIP: 58507N113

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / *W EXP 12/22/202
Total 13F shares
3,637,445
Share change
+234,111
Total reported value
$3,696,000
Price per share
$1.02
Number of holders
24
Value change
+$241,965
Number of buys
10
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 58507N113?
CUSIP 58507N113 identifies MTACW - MEDTECH ACQUISITION CORP - *W EXP 12/22/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MEDTECH ACQUISITION CORP - *W EXP 12/22/202 (MTACW) as of Q2 2021

As of 30 Jun 2021, MEDTECH ACQUISITION CORP - *W EXP 12/22/202 (MTACW) was held by 24 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,637,445 shares. The largest 10 holders included BlackRock Inc., Park West Asset Management LLC, ARISTEIA CAPITAL LLC, Linden Advisors LP, CITADEL ADVISORS LLC, SPRING CREEK CAPITAL LLC, Polar Asset Management Partners Inc., Vestcor Inc, Point72 Asset Management, L.P., and MYDA Advisors LLC. This page lists 24 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.